𝔖 Bobbio Scriptorium

✦ LIBER ✦

1140 POSTER First results of long term outcome in patients with inoperable or irresectable non-small cell lung cancer (NSCLC) treated with high-dose accelerated radiotherapy with or without concurrent or sequential chemotherapy

Book ID: 122089318
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 415 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(05)81434-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

884 Poster Influence of interfraction in

884 Poster Influence of interfraction interval on treatment outcome in patients with locally advanced nonmetastatic non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy. Final results in 536 patients

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

6582 POSTER Oral vinorelbine concomitant

6582 POSTER Oral vinorelbine concomitantly with thoracic radiotherapy (RT) in locally-advanced or inoperable stage III non-small cell lung cancer (NSCLC): interim results of a phase I dose escalation trial

✍ Krzakowski, M.; Gridelli, C.; Paccagnella, A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 76 KB

319 oral Mature results of a multicenter

319 oral Mature results of a multicenter German/French Phase-II trial of induction chemotherapy (CT) followed by hyperfractionated accelerated thoracic radiotherapy (HATRT) concurrent with CT followed or not by surgery (S) in inoperable non-small-cell lung cancer (NSCLC) stage III patients

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB

9019 POSTER DISCUSSION Safety Analysis o

9019 POSTER DISCUSSION Safety Analysis of Patient Subgroups Defined by Low and High Tumour Epidermal Growth Factor Receptor (EGFR) Expression in FLEX Study Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Chemotherapy With or Without Cetuximab as First-Line Therapy

✍ von Pawel, J.; Pirker, R.; Pereira, J.R.; Krzakowski, M.; Park, K.; Eberhardt, W 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

2136 Does concurrent chemotherapy improv

2136 Does concurrent chemotherapy improve local control and survival over radiotherapy alone or induction chemotherapy in stage III non-small cell lung cancer (NSCLC)? Results at 3 years in 140 patients (PTS) with a minimum follow-up of 24 months

✍ F. Reboul; Y. Brewer; P. Vincent; B. Chauvet; C.Félix Faure; M. Taulelle 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 133 KB

9108 POSTER Randomized Phase II Trial of

9108 POSTER Randomized Phase II Trial of Gemcitabine and Carboplatin (G/C) With or Without Dexamethasone (Dex) Pretreatment in Chemotherapy-naive Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC) – Results of Kyoto Thoracic Oncology Research Group (KTORG) Trial 0501

✍ Yoshioka, H.; Mio, T.; Nakatani, K.; Hirabayashi, M.; Yokoyama, T.; Iwasaku, M.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB